VNTR2/VNTR3 genotype in the FCGRT gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis

BACKGROUND: Intravenous immunoglobulin (IVIG) has been commonly used to treat myasthenia gravis exacerbation, but is still ineffective in nearly 30% of patients. A variable number of tandem repeat (VNTR) polymorphism in the FCGRT gene has been found to reduce the efficiency of IgG biologics. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Shengyao, Liu, Qing, Zhang, Xueping, Wen, Xinmei, Lei, Lin, Shen, Faxiu, Fan, Zhirong, Duo, Jianying, Lu, Yan, Di, Li, Wang, Min, Chen, Hai, Zhu, Wenjia, Xu, Min, Wang, Suobin, Da, Yuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844454/
https://www.ncbi.nlm.nih.gov/pubmed/33552238
http://dx.doi.org/10.1177/1756286420986747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844454/
https://www.ncbi.nlm.nih.gov/pubmed/33552238
http://dx.doi.org/10.1177/1756286420986747

Ejemplares similares